2006 Scientific Articles

Bines JE, Liem NT, Justice F, Son TN, Carlin JB, de Campo M, Jamsen K, Mulholland K, Barnett P, Barnes GL. Validation of a clinical case definition for acute intussusception in infants in Viet Nam and Australia.* Bulletin of the World Health Organization 2006;84(7):569–575.

Broder KR, Cortese MM, Iskander JK, Kretsinger K, Slade BA, Brown KH, Mijalski CM, Tiwari T, Weston EJ, Cohn AC, Srivastava PU, Moran JS, Schwartz B, Murphy TV; Advisory Committee on Immunization Practices (ACIP). Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006 Mar 24; 55(RR-3):1-34.
http://www.ncbi.nlm.nih.gov/pubmed/16557217

Centers for Disease Control and Prevention (CDC). Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine—United States, October 2005–February 2006. MMWR 2006;55(13):364–366.

Centers for Disease Control and Prevention (CDC). Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine—United States, June 2005–September 2006. MMWR 2006;55(41):1120–1124.

DiMiceli L, Pool V, Kelso JM, Shadomy SV, Iskander J; VAERS Team. Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS). Vaccine 2006;24(6):703–707.

Fowler GL, Baggs JM, Weintraub ES, Martin SW, McNeil MM, and Gust DA. Factors Influencing Laboratory Workers’ Decisions to Accept or Decline Anthrax Vaccine Adsorbed (AVA): Results of a Decision-Making Study in CDC’s Anthrax Vaccination Program. Pharmacoepidemiol. & Drug Saf. 2006 15:880-8.

France EK, Smith-Ray R, McClure D, Hambidge S, Xu S, Yamasaki K, Shay D, Weintraub E, Fry AM, Black SB, Shinefield HR, Mullooly JP, Jackson LA. Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits among infants.* Archives of Pediatrics & Adolescent Medicine 2006;160(12):1277–1283.

Glanz JM, McClure DL, Xu S, Hambidge SJ, Lee M, Kolczak MS, Kleinman K, Mullooly JP, France EK.Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations. Journal of Clinical Epidemiology 2006;59(8):808–818.

Hambidge SJ, Glanz JM, France EK, McClure D, Xu S, Yamasaki K, Jackson L, Mullooly JP, Zangwill KM, Marcy SM, Black SB, Lewis EM, Shinefield HR, Belongia E, Nordin J, Chen RT, Shay DK, Davis RL, DeStefano F; Vaccine Safety Datalink Team. Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. Journal of the American Medical Association 2006;296(16):1990–1997.

Iskander J, Pool V, Zhou W, English-Bullard R; The VAERS Team. Data mining in the US using the Vaccine Adverse Event Reporting System. Drug Safety 2006;29(5):375–384.

Jackson LA, Nelson JC, Whitney CG, Neuzil KM, Benson P, Malais D, Baggs J, Mullooly J, Black S, Shay DK. Assessment of the safety of a third dose of pneumococcal polysaccharide vaccine in the Vaccine Safety Datalink population. Vaccine 2006;24(2):151–156.

Jackson LA, Neuzil KM, Baggs J, Davis RL, Black S, Yamasaki KM, Belongia E, Zangwill KM, Mullooly J, Nordin J, Marcy SM, DeStefano F. Compliance with the recommendations for 2 doses of trivalent inactivated influenza vaccine in children less than 9 years of age receiving influenza vaccine for the first time: a Vaccine Safety Datalink study. Pediatrics 2006;118(5):2032–2037.

Lin ND, Kleinman K, Chan KA, Yu XJ, France EK, Wei F, Mullooly JP, Black S, Shay DK, Kolczak M, Lieu TA; Vaccine Safety Datalink Team. Variation in hepatitis B immunization coverage rates associated with provider practices after the temporary suspension of the birth dose. BMC Pediatrics 2006;6:31.

Muralles AA, Ray P, Black S, Shinefield H, Casey CG, Campbell S, Chen RT; Clinical Immunization Safety Assessment Network. Active telephone surveillance to evaluate adverse events among civilian smallpox vaccine recipients. Vaccine 2006;24(4):476–484.

Payne DC, Rose Jr CE, Kerrison J, Aranas A, Duderstadt S and McNeil MM. Anthrax Vaccination and Risk of Optic Neuritis in the United States Military, 1998-2003. Arch. Neurology 2006;63:871-875.

Prosser LA, Bridges CB, Uyeki TM, Hinrichsen VL, Meltzer MI, Noelle-Angelique MM, Schwartz B, Thompson WW, Fukuda K, Lieu TA. Health benefits, risks, and cost-effectiveness of influenza vaccination of children. Emerging Infectious Diseases 2006;12(10):1548–1558.

Ray P, Hayward J, Michelson D, Lewis E, Schwalbe J, Black S, Shinefield H, Marcy M, Huff K, Ward J, Mullooly J, Chen R, Davis R; Vaccine Safety Datalink Group. Encephalopathy after whole-cell pertussis or measles vaccination: lack of evidence for a causal association in a retrospective case-control study. Pediatric Infectious Disease Journal 2006;25(9):768–773.

Tapiainen T, Bär G, Bonhoeffer J, Heininger U. Evaluation of The Brighton Collaboration case definition of acute intussusception during active surveillance. Vaccine 2006;24(9):1483–1487.

Varricchio F, Reed J; VAERS Working Group. Follow-up study of medication errors reported to the vaccine adverse event reporting system (VAERS). Southern Medical Journal 2006;99(5):486–489.

Vermeer-de Bondt PE, Dzaferagić A, David S, van der Maas NA. Performance of The Brighton Collaboration case definition for hypotonic–hyporesponsive episode (HHE) on reported collapse reactions following infant vaccinations in the Netherlands. Vaccine 2006;24(49–50):7066–7070.

Woo EJ, Ball R, Landa R, Zimmerman AW, Braun MM; VAERS Working Group. Developmental regression and autism reported to the Vaccine Adverse Event Reporting System. Autism 2007;11(4):301–310.

Woo EJ, Miller NB, Ball R; VAERS Working Group. Adverse events after hepatitis A B combination vaccine. Vaccine 2006;24(14):2685–2691.